diagnosis and treatment for polycystic ovarian diseases related infertility according to gene expression ultrasound and immunohistochemistry

A diagnostic and Ayurvedic therapeutic approach for endometrial receptivity in patients of polycystic ovarian syndrome based on Radiological Uterine biophysical profile, Immunohistochemistry and Gene expression. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080959

Enrollment

Registered

2025-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of PCOS yearning conception. Patient giving consent for uttarabasti procedure and investigations And willing for follow ups.

Exclusion criteria

Exclusion criteria: <21 years and >40 years of age patient. Unmarried PCOS patients Patients with huge myoma and adenomyosis. Extensive cervical erosion and vaginal infection. HIV, HBsAg, HCV positive Patients.

Design outcomes

Primary

Measure	Time frame
diagnostic alteration in endometrial receptivityTimepoint: baseline, after 12 weeks	—

Secondary

Measure	Time frame
endometrial receptivity improvementsTimepoint: baseline, after 4weeks, after 8 weeks	—

Countries

India

Contacts

Public ContactDr Anuradha Roy

Banaras Hindu University, Varanasi

dranuradha369@gmail.com9956630433

Outcome results